Cargando…

Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain()

BACKGROUND: There are few studies on patients with heart failure (HF) hospitalized for COVID-19. Our aim is to describe the clinical characteristics of patients with HF hospitalized for COVID-19 and identify risk factors for in-hospital mortality upon admission. METHODS: We conducted a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salinas-Botrán, A., Sanz-Cánovas, J., Pérez-Somarriba, J., Pérez-Belmonte, L.M., Cobos-Palacios, L., Rubio-Rivas, M., de-Cossío-Tejido, S., Ramos-Rincón, J.M., Méndez-Bailón, M., Gómez-Huelgas, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497960/ https://www.ncbi.nlm.nih.gov/pubmed/34629304 http://dx.doi.org/10.1016/j.rceng.2021.06.004

Ejemplares similares

Características clínicas y factores de riesgo de mortalidad al ingreso en pacientes con insuficiencia cardíaca hospitalizados por COVID-19 en España
por: Salinas-Botrán, A., et al.
Publicado: (2022)

Respuesta a la carta «Tratamiento con glucocorticoides en pacientes con COVID-19 e insuficiencia cardíaca concurrente»
por: Salinas-Botrán, A., et al.
Publicado: (2022)

Answer to the “Glucocorticoid therapy in patients with COVID-19 and concurrent heart failure” correspondence()
por: Salinas-Botrán, A., et al.
Publicado: (2022)

Corticosteroid therapy in patients with heart failure hospitalized for COVID-19: a multicenter retrospective study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave
por: Gómez-Antúnez, M., et al.
Publicado: (2023)

Remission of type 2 diabetes: A critical appraisal
por: Ricci, Michele, et al.
Publicado: (2023)

Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2020)

De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Jansen-Chaparro, Sergio, et al.
Publicado: (2021)

Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2022)

Lifestyle Modification Program on a Metabolically Healthy Elderly Population with Overweight/Obesity, Young-Old vs. Old-Old. CONSEQUENCES of COVID-19 Lockdown in This Program
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Metabolically healthy obesity: Inflammatory biomarkers and adipokines in elderly population
por: Cobos-Palacios, Lidia, et al.
Publicado: (2022)

Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia
por: Sanz-Cánovas, Jaime, et al.
Publicado: (2022)

Factores de riesgo de mortalidad en pacientes con infección por SARS-CoV-2 y fibrilación auricular: datos del registro SEMI-COVID-19
por: Azaña Gómez, Javier, et al.
Publicado: (2022)

Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry
por: Azaña Gómez, Javier, et al.
Publicado: (2022)

Ethnicity and Clinical Outcomes in Patients Hospitalized for COVID-19 in Spain: Results from the Multicenter SEMI-COVID-19 Registry
por: Ramos-Rincon, Jose-Manuel, et al.
Publicado: (2022)

COVID-19 in Older Patients: Assessment of Post-COVID-19 Sarcopenia
por: López-Sampalo, Almudena, et al.
Publicado: (2023)

Derivation and validation of a risk score for admission to the Intensive Care Unit in patients with COVID-19()
por: Ena, J., et al.
Publicado: (2022)

Trends in Diabetes-Related Potentially Preventable Hospitalizations in Adult Population in Spain, 1997–2015: A Nation-Wide Population-Based Study
por: Gómez-Huelgas, Ricardo, et al.
Publicado: (2019)

Pacientes con EPOC hospitalizados por COVID-19 en España: comparación entre la primera y la segunda ola
por: Gómez-Antúnez, M., et al.
Publicado: (2023)

Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study)
por: García de Guadiana-Romualdo, Luis, et al.
Publicado: (2021)

Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain
por: Rodilla, Enrique, et al.
Publicado: (2020)

Remdesivir in Very Old Patients (≥80 Years) Hospitalized with COVID-19: Real World Data from the SEMI-COVID-19 Registry
por: Ramos-Rincon, Jose-Manuel, et al.
Publicado: (2022)

Obesity, Diabetes, and Cardiovascular Risk Burden in Systemic Lupus Erythematosus: Current Approaches and Knowledge Gaps—A Rapid Scoping Review
por: Hernández-Negrín, Halbert, et al.
Publicado: (2022)

Spatial distribution of hospital admissions for asthma in the central area of Asturias, Northern Spain
por: González-Iglesias, Verónica, et al.
Publicado: (2023)

Hospital admissions among immigrants from low-income and foreign citizens from high-income countries in Spain in 2000–2012
por: Ramos, José M., et al.
Publicado: (2016)

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
por: Garcia de Lucas, Maria Dolores, et al.
Publicado: (2022)

Enterovirus 75 and Aseptic Meningitis, Spain, 2005
por: Avellón, Ana, et al.
Publicado: (2006)

Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
por: Formiga, Francesc, et al.
Publicado: (2021)

Infective endocarditis according to type 2 diabetes mellitus status: an observational study in Spain, 2001–2015
por: de Miguel-Yanes, José M., et al.
Publicado: (2019)

Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure
por: Pérez-Belmonte, Luis M., et al.
Publicado: (2021)

Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
por: Casas-Rojo, José-Manuel, et al.
Publicado: (2023)

Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry()
por: Casas-Rojo, J.M., et al.
Publicado: (2020)

Long-Term Posttraumatic Growth in Victims of Terrorism in Spain
por: Fausor, Rocío, et al.
Publicado: (2022)

Respuesta
por: Méndez Bailón, Manuel, et al.
Publicado: (2022)

Sex Differences in the Incidence and Outcomes of Acute Myocardial Infarction in Spain, 2016–2018: A Matched-Pair Analysis
por: de Miguel-Yanes, José M., et al.
Publicado: (2021)

Silent COVID-19 in haemodialysis facilities in Cantabria, Spain: an ecological study
por: Rodrigo, Emilio, et al.
Publicado: (2020)

Spatial distribution of unscheduled hospital admissions for chronic obstructive pulmonary disease in the central area of Asturias, Spain
por: Martínez-Pérez, Isabel, et al.
Publicado: (2023)

Relationship between quadriceps femoris muscle architecture and muscle strength and physical function in older adults with heart failure with preserved ejection fraction
por: Fuentes-Abolafio, Iván J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rqqnrl15uj45og838qsce5s7u1